The first quarter was kind to our stocks, as they rose, on average, +8.8%, while the broad market fell. We comment on the sources of the gains and any recent news on our recommended stocks.

Today, I’m adding Cleveland, Ohio-based company Cleveland Cliffs (CLF), the largest flat-rolled steel producer in North America.

Becoming a great investor stems from a passion for learning. Learning new things is what gets me up every morning.

In Cabot SX Crypto Advisor, I will always make my best attempt to distill information concisely and clearly to you the audience so that you can make more informed, independent decisions.



This type of character development transcends assets and instead enables us to develop a rigorous, analytical framework. Sound and lucrative investments take conviction and time to compound. Therefore, concrete theses must be built piece by piece from solid research to identify great businesses and the correct holding period.

The market remains healthy and thus I continue to recommend that you remain fully invested in a diversified portfolio. My last two recommendations were chip companies that consumers can’t really “see,” but this week’s recommendation is a consumer-facing company, so you can easily “kick the tires.”
As for the current portfolio, there are no sales, but four stocks get downgraded to Hold, for various reasons.


Details inside.

From a top-down perspective, there’s really not many stones you can throw at the market given where it was just three weeks ago. However, when looking at individual stocks, it remains a tricky environment—specifically, most stocks that have approached their old highs have either stagnated or been soundly rejected, with the action has thus far been concentrated in the worst performers of the prior few months. To be clear, we see this more as descriptive than predictive, but we’ll have to see the selling-on-strength vibe change if the upmove is going to continue to gather steam.



This week’s list is again a mixed bag, with some growth but a lot of commodities and cyclicals, too. Our Top Pick is a big player in the steel space that just recently emerged from a big rest period.

Explorer stocks had another good week as markets adapt to the Russia-Ukraine conflict’s impact on commodity markets. Oil prices pulled back a bit following plans to release reserves. This week we look back in history at a global giant in agriculture and food that is backing our new-age recommendation hailing from Montana.

It’s been a challenging year for investors in cannabis stocks, but the good news today is that the stock market as a whole is stronger, and cannabis stocks are trending higher as well, especially in Canada, where the stocks were thoroughly oversold.

So I’m adding two new Canadian stocks to the portfolio.



Full details in the issue.

Thank you for subscribing to the Cabot Turnaround Letter. We hope you enjoy reading the April 2022 issue.



All companies are collections of assets. When companies are struggling, a new CEO can redirect how those assets are utilized – a valuable catalyst for a turnaround. We highlight three recent CEO changes and how they might help drive up the value of their companies.



While we have been slow and perhaps reluctant to consider cannabis companies, we find that the time has arrived to look more closely. We summarize our deep-dive into this emerging industry and its major participants, and suggest six companies with impressive growth yet trade at surprisingly low valuations.



Our featured recommendation this month is ZimVie (ZIMV), a company that was recently spun off from medical technology giant Zimmer Biomet. Its shares have been summarily sold by the market, creating what we believe is an attractive turnaround situation.



We note our second price target increase for Marathon Oil (MRO) and our move to sell shares of Baker Hughes (BKR).

Today, I’m adding an American petroleum contract drilling company, Helmerich & Payne, Inc. (HP).

In our view, the market still has a good amount of work to do, including when it comes to the intermediate-term trend of the major indexes, the trend of growth funds and for individual stocks, where breakouts to this point remain few and far between. Still, there’s also no question that, after weeks of bottom building, the evidence has certainly improved, with very solid action during the past two weeks among a variety of issues. We’re encouraged, but from here, it’s simply a matter of believing what we see. For now, we continue to favor holding some cash, buying on dips and keeping positions on the small side.


This week’s list is a mix of strong commodity names and some chip and growth titles that have perked up. Our Top Pick is a mid-cap energy name that should thrive in the quarters to come.

With the market continuing to improve, and chip stocks increasingly in demand, we add another chip stock (a very established one) to the portfolio today.
But we’re selling one stock too (VECO), taking profits and looking to reinvest them in something with greater potential.


Details inside.

The market’s evidence continues to improve, with more bullish breadcrumbs being dropped--last week, it came via a rare, blastoff-type indicator that triggered for just the fifth time since 1970. To be fair, our primary indicators are still iffy, so you shouldn’t throw caution to the wind, but we’re doing a bit more nibbling tonight, and aim to continue buying if the market can prove itself on the upside going forward.

Fear of the spread of a new virus has devolved into an economic disaster, at least in the short term.

Well, we’re in the thick of it. New citywide, statewide and national mandates are being pronounced daily, the stock market fell dramatically, my two daughters were sent home from college, three close relatives lost jobs/projects, and one close relative is a basket case over potentially losing his business.

To say that the coronavirus has infected the stock market would be to state the obvious. Less obvious is the answer to the question; what’s the antidote?

Ironically, China’s blue-chip CSI 300 Index hit its highest point this week since February 2018.

Monday’s market downturn was a bit breathtaking. First we had a stock market that was overdue for a pullback. Then the coronavirus hit, harming the Chinese economy, which in turn harms every business that sells products and services in China and manufactures products in China.

Remain cautious. The market has been gyrating wildly this week, holding above its lows from last Friday.

This has been about as ugly a couple of weeks in the market as you will ever see. On a closing basis, the market hit a low on February 28 and was down 12.5% from the February 19 highs. By total points lost, it was the fastest market correction in history.

The only news anybody seems to care about is the coronavirus. While that’s clearly a concern and not something to take lightly, I don’t think it changes the bigger picture trend that stocks are the place to be over the coming years.

This week is a reminder that markets don’t always go up. The big surprise was that it took so long for global markets to wake up to the threat.

Since January, this market had been merrily whistling along through the coronavirus risk. It was enough to cause a selloff for a day or two but not enough to derail the bull move to new highs that had been in place since early December. This week that changed.

The COVID-19 problem, as it pertains to the U.S. stock markets, is compounded by the fact that the S&P 500 index had risen about 12% since October.

Our first idea today is a tobacco company that has an 8.55% dividend yield, paid monthly.

This portfolio stock reported good second-quarter results and moves from Hold to Buy.

This Canadian telecom company just launched its 1.5 gigabit TELUS PureFibre, the only 100% fiber-to-the-premise network widely available from a major carrier in Western Canada.

This investment bank just came off a huge quarter, with revenues of $200.2 million compared with $128.1 million for the prior year quarter.

This is a is a fully integrated investment banking company.

The marijuana sector looks increasingly healthy, as the leading companies continue to post triple-digit growth rates and the leading stocks continue to climb higher.

Our second recommendation today is a sale of a previous idea.

There are five holdings in this fund.

As the semiconductor industry heats up again, this equipment maker is estimated to grow at an annual rate of 176.8% over the next five years.

The S&P 500 has had a tremendous run-up. It’s due for a correction, although it’s not yet indicating that the correction is imminent. Be cautious. Use stop-loss orders and/or pare back positions on stocks that have retraced early 2020 highs.

Our first idea today, an instrument maker, beat analysts’ estimates by $0.30 last quarter.

The company is currently building homes, primarily for first-time home buyers, in 19 U.S. states from coast to coast and the District of Columbia.

A few Cabot Options Trader subscribers have asked me about ways to protect gains in their portfolios, so I thought I would write to everyone with a couple of strategies using options to hedge your portfolio.

A subscriber recently asked me if I keep a journal of my trades. Many traders keep journals so they can look back at their trades and evaluate what they did right and what they did wrong.

Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.

Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.

Our Cabot Momentum Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Momentum Trader features.